SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question

Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)?    Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu